NCT07447050 Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial Status RECRUITING Phase PHASE2
NCT07414212 Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS) Status RECRUITING Phase PHASE1/PHASE2
NCT06676423 Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS Status COMPLETED Phase PHASE1
NCT06580002 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Status RECRUITING Phase PHASE2
NCT06270108 The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia Status RECRUITING Phase EARLY_PHASE1
NCT04761614 Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT04745299 Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS Status COMPLETED Phase PHASE3
NCT04454840 Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis Status COMPLETED Phase EARLY_PHASE1
NCT03722680 Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. Status SUSPENDED Phase PHASE2
NCT03660917 Riluzole in Patients With Spinocerebellar Ataxia Type 7 Status RECRUITING Phase PHASE2/PHASE3
NCT03537807 Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) Status NO_LONGER_AVAILABLE Phase N/A
NCT03347344 Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL) Status COMPLETED Phase PHASE3
NCT03272802 Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) Status UNKNOWN Phase PHASE2/PHASE3
NCT03127267 Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients Status RECRUITING Phase PHASE3
NCT02859792 Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition Status UNKNOWN Phase PHASE2
NCT02796755 Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation Status COMPLETED Phase PHASE4
NCT02645461 Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS Status COMPLETED Phase NA
NCT02588677 Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2/PHASE3